MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a ...

MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...

No-moat Telix Pharmaceuticals’ 2024 revenue rose 56% to AUD 783 million, in line with our forecast. Practically all revenue is attributable to US sales of Illuccix, a diagnostic tool for ...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher on Friday morning. At the time of writing, the pharmaceutical company's shares are up 13% to a record high of $30.00.

Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies.

Thank you for standing by, and welcome to the Telix Pharmaceuticals Limited FY 2024 Results Call. All participants are in a listen-only mode. There will be a presentation followed by a question ...

Chad Watkins, General Manager, Isotope Strategy, Telix, said, “A lead-212 generator that produces minimal waste and fits within the current radiopharmacy footprint is a step change in the ...

MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a ...